WILMINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its fourth fiscal quarter and fiscal year 2025, which ended on September 27, 2025. Symbotic reported revenue of $618 million, a net loss of $19 million and adjusted EBITDA(1) of $49 million for the fourth quarter of fiscal year 2025.
In comparison, Symbotic posted revenue of $565 million, net income of $16 million and adjusted EBITDA(1) of $42 million in the fourth quarter of fiscal year 2024.
Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million at the end of the fourth quarter of fiscal year 2025.
For the full fiscal year 2025, Symbotic reported revenue of $2,247 million, reflecting 26% growth year-over-year, a net loss of $91 million, and adjusted EBITDA(1) of $147 million.
"We delivered on our commitments to achieve strong top-line growth, a significant rise in operational systems, and strong margin expansion in fiscal year 2025 as we continue to enhance our value to customers," said Rick Cohen, Symbotic Chairman and Chief Executive Officer. "We also added Medline, our first customer in the health care vertical, and enter fiscal year 2026 enthusiastic about our prospects to broaden opportunities with customers."
"Revenue exceeded our expectations, and we delivered strong gross margin expansion and free cash flow in the fiscal fourth quarter of 2025," said Izzy Martins, Symbotic Chief Financial Officer. "Looking ahead, the start of fiscal year 2026 is unfolding consistent with the expectations we outlined last quarter as our customers continue their transition to our next generation storage structure."
OUTLOOK
For the first quarter of fiscal 2026, Symbotic expects revenue of $610 million to $630 million, and adjusted EBITDA(2) of $49 million to $53 million.
WEBCAST INFORMATION
Symbotic will host a webcast today at 5:00 pm ET to discuss its fourth quarter and fiscal year 2025 results. The webcast link is: https://edge.media-server.com/mmc/go/Symbotic-Q4-2025.
________________________________
(1) Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is a non-GAAP financial measure as defined below under "Use of Non-GAAP Financial Information." See the tables below for reconciliations to net income (loss), the most comparable GAAP measure.
(2) Symbotic is not providing guidance for net income (loss), which is the most comparable GAAP financial measure to adjusted EBITDA, because information reconciling forward-looking adjusted EBITDA to net income (loss) is unavailable to it without unreasonable effort. Symbotic is not able to provide reconciliations of adjusted EBITDA to GAAP financial measures because certain items required for such reconciliations are outside of Symbotic's control and/or cannot be reasonably predicted, such as the provision for stock-based compensation.
ABOUT SYMBOTIC
Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world's largest retail, wholesale, and food & beverage companies. Applying next-generation technology, high-density storage and machine learning to solve today's complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com.
USE OF NON-GAAP FINANCIAL INFORMATION
Symbotic reports its financial results in accordance with Generally Accepted Accounting Principles in the United States ("U.S. GAAP"). This press release contains financial measures that are not recognized under U.S. GAAP ("non-GAAP financial measures"), including adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow. These non-GAAP financial measures have limitations as an analytical tool as they do not have a standardized meaning prescribed by U.S. GAAP. The non-GAAP financial measures Symbotic uses may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as that of other companies and, therefore, are unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP financial measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding the results of operations from management's perspective. Accordingly, non-GAAP financial measures should not be considered a substitute for, in isolation from, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP financial measures presented in this press release are reconciled to their closest reported U.S. GAAP financial measures. Symbotic recommends that investors review the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures provided in the financial statement tables included below in this press release, and not rely on any single financial measure to evaluate its business.
Symbotic defines adjusted EBITDA, a non-GAAP financial measure, as GAAP net income (loss) excluding the following items: interest income; income taxes; depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; equity method investment; internal control remediation; business transformation costs; fair value adjustments on strategic investments; restructuring charges; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines adjusted gross profit, a non-GAAP financial measure, as GAAP gross profit excluding the following items: depreciation, stock-based compensation, and restructuring charges. Symbotic defines adjusted gross profit margin, a non-GAAP financial measure, as adjusted gross profit divided by total revenue. Symbotic defines adjusted research and development expenses, a non-GAAP financial measure, as GAAP research and development expenses excluding the following items: depreciation and amortization of tangible and intangible assets and stock-based compensation. Symbotic defines adjusted selling, general, and administrative expenses, a non-GAAP financial measure, as GAAP selling, general, and administrative expenses excluding the following items: depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; internal control remediation; business transformation costs; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less purchases of property and equipment and capitalization of internal use software development costs. In addition to Symbotic's financial results determined in accordance with U.S. GAAP, Symbotic believes that adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow non-GAAP financial measures, are useful in evaluating the performance of Symbotic's business because they highlight trends in its core business.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, Symbotic's expectations or predictions of future financial or business performance or conditions. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning our possible or assumed future actions, business strategies, events, backlog or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words "believes," "estimates," "expects," "projects," "forecasts," "may," "will," "should," "seeks," "plans," "scheduled," "anticipates" or "intends" or similar expressions.
Forward-looking statements include, but are not limited to, statements about the ability of or expectations regarding, Symbotic to:
-- meet the technical requirements of existing or future supply agreements
with its customers, including with respect to existing backlog;
-- expand its target customer base and maintain its existing customer base;
-- realize the benefits expected from our GreenBox Systems LLC ("GreenBox")
joint venture, the commercial agreement with GreenBox, the commercial
agreement with Nueva Wal Mart de México, S. de R.L. de C.V and the
acquisition of the Advanced Systems and Robotics business from Walmart;
-- realize its outlook, including its system gross margin;
-- anticipate industry trends;
-- maintain and enhance its system;
-- anticipate rapid technological changes;
-- execute its growth strategy;
-- develop, design and sell systems that are differentiated from those of
competitors;
-- execute its research and development strategy;
-- acquire, maintain, protect and enforce intellectual property;
-- attract, train and retain effective officers, key employees or directors;
-- comply with laws and regulations applicable to its business;
-- stay abreast of modified or new laws and regulations applying to its
business;
-- successfully defend litigation;
-- issue equity securities in connection with future transactions;
-- meet future liquidity requirements and, if applicable, comply with
restrictive covenants related to long-term indebtedness;
-- timely and effectively remediate any material weaknesses in its internal
control over financial reporting;
-- maintain the listing of the Symbotic common stock on Nasdaq; and
-- effectively respond to general economic and business conditions.
Forward-looking statements also include, but are not limited to, statements with respect to:
-- the future performance of Symbotic's business and operations;
-- expectations regarding revenues, expenses, adjusted EBITDA and
anticipated cash needs;
-- expectations regarding cash flow, liquidity and sources of funding;
-- the next generation storage structure;
-- expectations regarding capital expenditures;
-- the anticipated benefits of Symbotic's leadership structure;
-- the effects of pending and future legislation, regulation and trade
practices, including tariffs;
-- business disruption;
-- disruption to the business due to Symbotic's dependency on Walmart;
-- increasing competition in the warehouse automation industry;
-- any delays in the design, production or launch of Symbotic's systems and
products;
-- the failure to meet customers' requirements under existing or future
contracts or customer's expectations as to price or pricing structure;
-- any defects in new products or enhancements to existing products;
-- the fluctuation of operating results from period to period due to a
number of factors, including the pace of customer adoption of Symbotic's
new products and services and any changes in its product mix that shift
too far into lower gross margin products; and
-- any consequences associated with joint ventures and legislative and
regulatory actions and reforms.
Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed in Symbotic's Annual Report on Form 10-K for the fiscal year ended September 27, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC") on November 24, 2025. These risk factors will be important to consider in determining future results and should be reviewed in their entirety. These forward-looking statements are expressed in good faith, and Symbotic believes there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management's current expectations and plans relating to the future, and the reader is cautioned not to place undue reliance on these forward-looking statements because of their inherent uncertainty and to appreciate the limited purposes for which they are being used by management. While we believe that the assumptions and expectations reflected in the forward-looking statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-looking statements speak only as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. Symbotic is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Symbotic has filed or will file from time to time with the SEC.
In addition to factors previously disclosed in Symbotic's Annual Report on Form 10-K for the fiscal year ended September 27, 2025 filed with the SEC on November 24, 2025 and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance.
Any financial projections in this press release or discussed in the webcast are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Symbotic's control. While all projections are necessarily speculative, Symbotic believes that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection extends from the date of preparation. The assumptions and estimates underlying the projected results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. The inclusion of projections in this communication should not be regarded as an indication that Symbotic, or its representatives, considered or considers the projections to be a reliable prediction of future events.
Annualized, projected and estimated numbers are not forecasts and may not reflect actual results.
This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Symbotic and is not intended to form the basis of an investment decision in Symbotic. The forward-looking statements contained in this press release and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.
INVESTOR RELATIONS CONTACT
Charlie Anderson
Vice President, Investor Relations & Corporate Development
ir@symbotic.com
MEDIA INQUIRIES
mediainquiry@symbotic.com
Symbotic Inc. and Subsidiaries
Consolidated Statements of Operations
Three Months Ended Year Ended
---------------------------------------------
(in thousands,
except share and
per share
information) September 27, 2025 June 28, 2025 September 28, 2024 September 27, 2025 September 28, 2024
--------------------- --------------------- --------------------- --------------------- ----------------------
Revenue:
Systems $ 582,329 $ 559,108 $ 536,447 $ 2,118,868 $ 1,705,440
Software
maintenance
and support 9,271 8,121 5,893 29,602 14,173
Operation
services 26,857 24,892 22,226 98,452 68,566
------------------- ------------------- ------------------- ------------------- ------------------
Total
revenue 618,457 592,121 564,566 2,246,922 1,788,179
Cost of revenue:
Systems 456,157 457,911 442,009 1,710,446 1,466,841
Software
maintenance
and support 2,827 1,756 2,748 8,562 8,949
Operation
services 32,352 24,832 23,392 105,304 66,723
------------------- ------------------- ------------------- ------------------- ------------------
Total cost
of revenue 491,336 484,499 468,149 1,824,312 1,542,513
------------------- ------------------- ------------------- ------------------- ------------------
Gross profit 127,121 107,622 96,417 422,610 245,666
------------------- ------------------- ------------------- ------------------- ------------------
Operating
expenses:
Research and
development
expenses 58,732 52,147 40,130 216,013 173,457
Selling,
general, and
administrative
expenses 83,638 75,670 45,399 298,730 188,934
Restructuring
charges 6,513 16,361 -- 22,873 --
------------------- ------------------- ------------------- ------------------- ------------------
Total
operating
expenses 148,883 144,178 85,529 537,616 362,391
------------------- ------------------- ------------------- ------------------- ------------------
Operating
income (loss) (21,762) (36,556) 10,888 (115,006) (116,725)
Other income, net 8,076 8,451 9,416 36,063 37,042
------------------- ------------------- ------------------- ------------------- ------------------
Income (loss)
before income
tax (13,686) (28,105) 20,304 (78,943) (79,683)
Income tax benefit
(expense) 423 (44) (4,110) 1,627 (4,212)
Loss from equity
method
investment (5,885) (3,776) (240) (13,716) (777)
------------------- ------------------- ------------------- ------------------- ------------------
Net income
(loss) (19,148) (31,925) 15,954 (91,032) (84,672)
Net income (loss)
attributable to
noncontrolling
interests (15,526) (26,012) 13,118 (74,095) (71,182)
------------------- ------------------- ------------------- ------------------- ------------------
Net income
(loss)
attributable
to common
stockholders $ (3,622) $ (5,913) $ 2,836 $ (16,937) $ (13,490)
=================== =================== =================== =================== ==================
Income (loss) per
share of Class A
Common Stock:
Basic and
Diluted((1) $ (0.03) $ (0.05) $ 0.03 $ (0.16) $ (0.14)
Weighted-average
shares of Class A
Common Stock
outstanding:
Basic 111,697,093 109,201,745 104,146,479 108,670,159 95,697,368
Diluted (2) n/a n/a 108,646,977 n/a n/a
(1) For the periods presented, basic and diluted EPS
were calculated as the same value and as such presented
on the same line.
(2) Periods in which the Company was in a net loss
position diluted weighted-average shares of Class
A Common Stock outstanding is the same as basic and
as such indicated with "n/a".
Symbotic Inc. and Subsidiaries
Reconciliation of Non-GAAP Financial Measures
The following table reconciles GAAP net income (loss)
to Adjusted EBITDA:
Three Months Ended Year Ended
--------------------------------------
September 27, September 28, September 27,
(in thousands) 2025 June 28, 2025 2024 2025 September 28, 2024
----------------- ----------------- ---------------- ----------------- -------------------
Net income (loss) $ (19,148) $ (31,925) $ 15,954 $ (91,032) $ (84,672)
Interest income (8,085) (8,373) (9,353) (31,456) (36,907)
Income tax
(benefit)
expense (423) 44 4,110 (1,627) 4,212
Depreciation
and
amortization 8,648 12,940 5,780 39,617 20,845
Stock-based
compensation 53,852 50,279 26,100 180,834 120,608
Business
combination
transaction
expenses 40 422 324 7,562 324
Joint venture
formation
fees -- -- -- -- 1,089
Restructuring
charges 6,103 16,361 (775) 22,233 33,431
Internal
control
remediation 1,360 1,795 8,406 --
Business
transformation
costs 1,210 75 3,685 --
Fair value
adjustments on
strategic
investments -- -- (4,481) --
Equity
financing
transaction
costs -- -- -- -- 1,985
Equity method
investment 5,885 3,776 240 13,716 777
--------------- --------------- -------------- --------------- ---------------
Adjusted EBITDA $ 49,442 $ 45,394 $ 42,380 $ 147,457 $ 61,692
=============== =============== ============== =============== ===============
The following table reconciles GAAP gross profit to
Adjusted gross profit:
Three Months Ended Year Ended
---------------------------------------
(in thousands) September 27, 2025 June 28, 2025 September 28, 2024 September 27, 2025 September 28, 2024
--------------------- -------------------- --------------------- --------------------- --------------------
Gross profit $ 127,121 $ 107,622 $ 96,417 $ 422,610 $ 245,666
Depreciation 1,457 3,538 2,208 10,414 7,748
Stock-based
compensation 8,672 16,034 3,260 39,678 15,654
Restructuring
charges (411) -- (775) (642) 33,431
--------------- --------------- --------------- --------------- ---------------
Adjusted gross
profit $ 136,839 $ 127,194 $ 101,110 $ 472,060 $ 302,499
=============== =============== =============== =============== ===============
Gross profit
margin 20.6 % 18.2 % 17.1 % 18.8 % 13.7 %
Adjusted gross
profit margin 22.1 % 21.5 % 17.9 % 21.0 % 16.9 %
The following table reconciles GAAP research and development
expenses to Adjusted research and development expenses:
Three Months Ended Year Ended
------------------------------------------------------- --------------------------------------
September 27, September 28, September 27,
(in thousands) 2025 June 28, 2025 2024 2025 September 28, 2024
----------------- ----------------- ----------------- ----------------- -------------------
Research and
development
expenses $ 58,732 $ 52,147 $ 40,130 $ 216,013 $ 173,457
Depreciation
and
amortization (4,946) (7,133) (1,647) (19,990) (4,883)
Stock-based
compensation (16,494) (12,860) (11,553) (57,213) (53,266)
--------------- --------------- --------------- --------------- ---------------
Adjusted research
and development
expenses $ 37,292 $ 32,154 $ 26,930 $ 138,810 $ 115,308
=============== =============== =============== =============== ===============
The following table reconciles GAAP selling, general,
and administrative expenses to Adjusted selling, general,
and administrative expenses:
Three Months Ended Year Ended
------------------------------------------------------- --------------------------------------
September 27, September 28, September 27,
(in thousands) 2025 June 28, 2025 2024 2025 September 28, 2024
----------------- ----------------- ----------------- ----------------- -------------------
Selling, general,
and administrative
expenses $ 83,638 $ 75,670 $ 45,399 $ 298,730 $ 188,934
Depreciation
and
amortization (2,245) (2,270) (1,926) (9,214) (8,220)
Stock-based
compensation (28,686) (21,385) (11,286) (83,943) (51,686)
Business
combination
transaction
expenses (40) (422) (324) (7,562) (324)
Internal
control
remediation (1,359) (1,795) -- (8,406) --
Business
transformation
costs (1,210) (75) -- (3,685) --
Joint venture
formation
fees -- -- -- -- (1,089)
Equity
financing
transaction
costs -- -- -- -- (1,985)
--------------- --------------- --------------- --------------- ---------------
Adjusted selling,
general, and
administrative
expenses $ 50,098 $ 49,723 $ 31,863 $ 185,920 $ 125,630
=============== =============== =============== =============== ===============
The following table reconciles GAAP net cash provided
by (used in) operating activities to free cash flow:
Three Months Ended Year Ended
---------------------------------------
September 27, September 27,
(in thousands) 2025 June 28, 2025 September 28, 2024 2025 September 28, 2024
----------------- ------------------ ------------------ ----------------- --------------------
Net cash provided
by (used in)
operating
activities $ 530,680 $ (138,343) $ (99,383) $ 866,939 $ (58,077)
Purchases of
property and
equipment and
capitalization
of internal
use software
development
costs (36,246) (14,867) (21,367) (79,030) (44,374)
--------------- ---------------- ---------------- --------------- ----------------
Free cash flow $ 494,434 $ (153,210) $ (120,750) $ 787,909 $ (102,451)
=============== ================ ================ =============== ================
Symbotic Inc. and Subsidiaries
Supplemental Common Share Information
Total Common Shares issued and outstanding:
September 27, 2025 September 28, 2024
------------------- ---------------------
Class A Common Shares issued
and outstanding 112,635,932 104,689,377
Class V-1 Common Shares issued
and outstanding 74,693,311 76,965,386
Class V-3 Common Shares issued
and outstanding 403,559,196 404,309,196
------------------- -------------------
590,888,439 585,963,959
=================== ===================
Symbotic Inc. and Subsidiaries
Consolidated Balance Sheets
(in thousands, except
share data) September 27, 2025 September 28, 2024
-------------------- ----------------------
ASSETS
Current assets:
Cash and cash
equivalents $ 1,244,993 $ 727,310
Accounts receivable 186,705 201,548
Unbilled accounts
receivable 181,658 218,233
Inventories 164,390 106,136
Deferred expenses 20,532 1,058
Prepaid expenses and
other current
assets 92,050 101,252
------------------ ------------------
Total current
assets 1,890,328 1,355,537
Property and equipment,
net 117,649 97,109
Intangible assets, net 79,149 3,664
Goodwill 59,871 --
Equity method investment 123,034 81,289
Other assets 131,166 40,953
------------------ ------------------
Total assets $ 2,401,197 $ 1,578,552
================== ==================
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable $ 286,669 $ 175,188
Accrued expenses and
other current
liabilities 200,442 165,644
Deferred revenue 1,242,312 676,314
------------------ ------------------
Total current
liabilities 1,729,423 1,017,146
Deferred revenue 124,932 129,233
Other liabilities 63,629 42,043
------------------ ------------------
Total liabilities 1,917,984 1,188,422
------------------ ------------------
Commitments and
contingencies -- --
Equity:
Class A Common Stock,
3,000,000,000 shares
authorized,
112,635,932 and
104,689,377 shares
issued and
outstanding at
September 27, 2025
and September 28,
2024, respectively 13 13
Class V-1 Common
Stock, 1,000,000,000
shares authorized,
74,693,311 and
76,965,386 shares
issued and
outstanding at
September 27, 2025
and September 28,
2024, respectively 7 7
Class V-3 Common
Stock, 450,000,000
shares authorized,
403,559,196 and
404,309,196 shares
issued and
outstanding at
September 27, 2025
and September 28,
2024, respectively 40 40
Additional paid-in
capital 1,564,815 1,523,692
Accumulated deficit (1,340,862) (1,323,925)
Accumulated other
comprehensive loss (2,695) (2,594)
------------------ ------------------
Total
stockholders'
equity 221,318 197,233
Noncontrolling
interest 261,895 192,897
------------------ ------------------
Total equity 483,213 390,130
------------------ ------------------
Total liabilities and
equity $ 2,401,197 $ 1,578,552
================== ==================
Symbotic Inc. and Subsidiaries
Consolidated Statements of Cash Flows
Three Months Ended Year Ended
(in thousands) September 27, 2025 June 28, 2025 September 28, 2024 September 27, 2025 September 28, 2024
------------------- ------------------ ------------------ --------------------
Cash flows from
operating activities:
Net income (loss) $ (19,148) $ (31,925) $ 15,954 $ (91,032) $ (84,672)
Adjustments to
reconcile net income
(loss) to net cash
provided by (used in)
operating activities:
Depreciation and
amortization 8,650 12,941 5,781 39,604 20,847
Amortization of
leases 1,353 1,261 651 4,525 2,633
Restructuring of
leases 3,469 -- -- 3,469 --
Loss from equity
method investment 5,885 3,776 240 13,716 777
Foreign currency
(gains) losses,
net 40 (61) -- (33) (8)
Loss on disposal of
assets 63 -- 337 264 337
Gain on investments -- -- -- -- (10,084)
Provision for excess
and obsolete
inventory 2,247 3,921 (775) 7,148 33,330
Deferred taxes, net (4,205) -- 3,917 (4,205) 3,917
Stock-based
compensation 64,368 49,440 25,350 183,936 112,208
Gain from strategic
investment fair
value adjustment -- -- -- (4,481) --
Changes in operating
assets and
liabilities:
Accounts receivable (50,495) 1,389 (101,010) 15,075 (132,305)
Inventories (28,690) 3,470 30,202 (58,876) 103
Prepaid expenses and
other current
assets 7,685 (37,107) (114,889) 70,386 (112,050)
Deferred expenses (1,589) 27,503 5,690 21,993 (4,936)
Other assets 25,624 (9,449) (4,088) 8,696 (9,040)
Accounts payable 56,360 (4,407) 47,399 96,904 65,270
Accrued expenses and
other current
liabilities 17,969 12,532 (10,126) 10,356 38,467
Deferred revenue 489,118 (171,331) 6,309 606,406 18,318
Acquisition-related
consideration paid
to customer (45,000) -- -- (45,000) --
Other liabilities (3,024) (296) (10,325) (11,912) (1,189)
Net cash provided
by (used in)
operating
activities 530,680 (138,343) (99,383) 866,939 (58,077)
----------------- ---------------- ---------------- ----------------- ----------------
Cash flows from
investing activities:
Purchases of
property and
equipment and
capitalization of
software
development costs (36,246) (14,867) (21,367) (79,030) (44,374)
Proceeds from
maturities of
marketable
securities -- -- -- -- 340,000
Purchases of
marketable
securities -- -- -- -- (48,660)
Acquisitions of
strategic
investments (87,656) (24,233) (23,996) (129,881) (90,485)
Cash paid for
business
acquisitions 58,169 -- -- (141,831) --
Net cash provided
by (used in)
investing
activities (65,733) (39,100) (45,363) (350,742) 156,481
----------------- ---------------- ---------------- ----------------- ----------------
Cash flows from
financing activities:
Payment for taxes
related to net
share settlement
of stock-based
compensation
awards -- -- -- (3,012) (3,181)
Net proceeds from
issuance of
common stock
under employee
stock purchase
plan 1,622 -- 2,308 4,855 5,743
Proceeds from
issuance of Class
A Common Stock -- -- -- -- 257,985
Distributions to
or on behalf of
Symbotic Holdings
LLC partners -- 57 (561) (1,175) (48,215)
Proceeds from
exercise of
warrants -- -- -- -- 158,704
Net cash provided
by financing
activities 1,622 57 1,747 668 371,036
----------------- ---------------- ---------------- ----------------- ----------------
Effect of exchange rate
changes on cash, cash
equivalents, and
restricted cash (16) 24 21 (26) (4)
----------------- ---------------- ---------------- ----------------- ----------------
Net increase (decrease)
in cash, cash
equivalents, and
restricted cash 466,553 (177,362) (142,978) 516,839 469,436
Cash, cash equivalents,
and restricted cash -
beginning of period 780,640 958,002 873,332 730,354 260,918
Cash, cash equivalents,
and restricted cash -
end of period $ 1,247,193 $ 780,640 $ 730,354 $ 1,247,193 $ 730,354
================= ================ ================ ================= ================
Three Months Ended Year Ended
(in thousands) September 27, 2025 June 28, 2025 September 28, 2024 September 27, 2025 September 28, 2024
------------------- ------------------ ------------------ --------------------
Reconciliation of cash,
cash equivalents, and
restricted cash:
Cash and cash
equivalents $ 1,244,993 $ 777,576 $ 727,310 $ 1,244,993 $ 727,310
Restricted cash 2,200 3,064 3,044 2,200 3,044
Cash, cash
equivalents, and
restricted cash $ 1,247,193 $ 780,640 $ 730,354 $ 1,247,193 $ 730,354
================= ================ ================ ================= ================
(END) Dow Jones Newswires
November 24, 2025 16:01 ET (21:01 GMT)